Literature DB >> 9570568

Streptococcal cell wall-induced arthritis: requirements for IL-4, IL-10, IFN-gamma, and monocyte chemoattractant protein-1.

R C Schimmer1, D J Schrier, C M Flory, K D Laemont, D Tung, A L Metz, H P Friedl, M C Conroy, J S Warren, B Beck, P A Ward.   

Abstract

Intra-articular injection of streptococcal cell wall Ag followed by i.v. challenge ("reactivation") results in a destructive lymphocyte-dependent monoarticular arthritis. To further define the role of immune mechanisms in the model, Abs to Th1 and Th2-related cytokines were evaluated. Treatment of rats with antibodies to IL-4 reduced swelling, while treatment with anti-IL-10 or anti-IFN-gamma either had no effect or slightly enhanced the inflammatory response. These results suggest that Th-2 immune mechanisms may be, at least in part, operative in the model. To more precisely define the role of IL-4, the effects of anti-IL-4 on monocyte chemoattractant protein-1 (MCP-1) expression were evaluated. Initial studies demonstrated that mRNA (as determined by in situ hybridization) and protein (as determined by immunofluorescence) for MCP-1 were detectable in inflamed synovial tissue in a time-dependent manner. Anti-IL-4 treatment significantly reduced the expression of mRNA for MCP-1 24 and 72 h after reactivation. In addition, anti-MCP-1 inhibited swelling and reduced influx of (111)In-labeled T cells. These data suggest that the reactivation model of streptococcal cell wall Ag-induced arthritis is Th-2 dependent, and that an inter-relationship exists between IL-4 and the expression of MCP-1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570568

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis.

Authors:  S Youssef; G Maor; G Wildbaum; N Grabie; A Gour-Lavie; N Karin
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders.

Authors:  T Ellingsen; N Hornung; B K Møller; J H Poulsen; K Stengaard-Pedersen
Journal:  Ann Rheum Dis       Date:  2006-08-11       Impact factor: 19.103

Review 3.  Animal models of rheumatoid arthritis and related inflammation.

Authors:  B Joe; M M Griffiths; E F Remmers; R L Wilder
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

4.  Enzyme degradation and proinflammatory activity in arthritogenic and nonarthritogenic Eubacterium aerofaciens cell walls.

Authors:  X Zhang; M Rimpiläinen; E Simelyte; P Toivanen
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Sustained macrophage infiltration upon multiple intra-articular injections: an improved rat model of rheumatoid arthritis for PET guided therapy evaluation.

Authors:  Durga M S H Chandrupatla; Karin Weijers; Yoony Y J Gent; Inge de Greeuw; Adriaan A Lammertsma; Gerrit Jansen; Conny J van der Laken; Carla F M Molthoff
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

6.  Etanercept ameliorates inflammation and pain in a novel mono-arthritic multi-flare model of streptococcal cell wall induced arthritis.

Authors:  Kalyan Chakravarthy; Robert Faltus; Gain Robinson; Raquel Sevilla; John Shin; Mark Zielstorff; Alan Byford; Erica Leccese; Michael J Caniga; SuChun Hseih; Shuli Zhang; Chi-Sung Chiu; Jie Zhang-Hoover; Lily Y Moy; Robbie L McLeod; Dana Stoffregen; Weisheng Zhang; Anwar Murtaza; Milenko Cicmil
Journal:  BMC Musculoskelet Disord       Date:  2014-12-04       Impact factor: 2.362

7.  Imaging and Methotrexate Response Monitoring of Systemic Inflammation in Arthritic Rats Employing the Macrophage PET Tracer [18F]Fluoro-PEG-Folate.

Authors:  Durga M S H Chandrupatla; Gerrit Jansen; Elise Mantel; Philip S Low; Takami Matsuyama; René P Musters; Albert D Windhorst; Adriaan A Lammertsma; Carla F M Molthoff; Conny J van der Laken
Journal:  Contrast Media Mol Imaging       Date:  2018-02-21       Impact factor: 3.161

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.